News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA™ from Genetic Medicine Developers

BNB Plus: Fiscal Q1 Earnings Snapshot [Yahoo! Finance]

BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

Applied Dna Sciences (NASDAQ:BNBX) is now covered by analysts at Weiss Ratings. They set a "sell (e+)" rating on the stock.

Form 4 BNB PLUS CORP. For: Mar 27 Filed by: SHAMASH YACOV A

Form 4 BNB PLUS CORP. For: Mar 27 Filed by: CATELL ROBERT B

Form 4 BNB PLUS CORP. For: Mar 27 Filed by: Murrah Judith

Form 4 BNB PLUS CORP. For: Mar 27 Filed by: Kruger Joshua

Form 4 BNB PLUS CORP. For: Mar 27 Filed by: Ceccoli Joseph D.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}